Bill

Bill > HB1239


OK HB1239

OK HB1239
Practice of pharmacy; certain drugs as over-the-counter; prescription; penalties; effective date.


summary

Introduced
02/03/2025
In Committee
02/04/2025
Crossed Over
Passed
Dead

Introduced Session

2025 Regular Session

Bill Summary

An Act relating to the practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties; providing for codification; and providing an effective date.

AI Summary

This bill requires chloroquine, hydroxychloroquine, and ivermectin to be designated as over-the-counter drugs, meaning patients can purchase these medications without needing a prescription from a healthcare provider. The legislation specifically prohibits pharmacists and pharmacies from requiring a prescription for these drugs. If the State Board of Pharmacy determines that a pharmacist or pharmacy is violating this requirement, they are mandated to immediately revoke the professional license of the pharmacist or the pharmacy's operational license and impose a substantial fine of $100,000 for each occurrence. These drugs, which have been used in various medical treatments (notably hydroxychloroquine and ivermectin gained attention during the COVID-19 pandemic), would now be directly accessible to consumers without prior medical consultation. The bill is set to take effect on November 1, 2025, giving pharmacies and healthcare providers advance notice of the upcoming change in drug dispensation regulations.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Referred to Public Health (on 02/04/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...